Wuhan Keqian Biology Co. Ltd.SSE: 688526

Announcement on Convening the Q3 2024 Performance Briefing

Oct 31, 2024 · Issued by Wuhan Keqian Biology Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 31, 2024

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2024-performance-briefing-386

Announcement on Convening the Q3 2024 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Wuhan Keqian Biology Co. Ltd. on 6ix

Earlier from Wuhan Keqian Biology

Announcement on Abnormal Fluctuations in Stock TradingOct 10, 2024
Announcement on the Result of Shareholding Reduction by the Shareholder and Supervisor with Over 5% SharesOct 9, 2024
Announcement on Renewal of Concerted Action Agreement by Actual ControllerSep 21, 2024
Announcement on Convening the 2024 Semi-annual Performance BriefingSep 20, 2024
2024 Semi-annual ReportAug 30, 2024

Later from Wuhan Keqian Biology

Announcement on Resolutions of the 6th Meeting of the 4th Board of SupervisorsDec 10, 2024
Announcement on Voluntary Disclosure of Obtaining Veterinary Drug GMP Certificate and Veterinary Drug Production LicenseJan 1, 2025
Announcement on Progress in Repurchasing Shares through Call AuctionFeb 6, 2025
Announcement on Implementation Results of Share Repurchase and Share ChangesFeb 21, 2025
Preliminary Earnings Estimate for 2024Feb 27, 2025

All Wuhan Keqian Biology news releases

Follow Wuhan Keqian Biology into a list and get an email when it puts out news.

Follow Wuhan Keqian Biology